Literature DB >> 9250200

Early closure of European Pimagedine trial. Steering Committee. Safety Committee.

G Viberti, G Slama, G Pozza, A Czyzyk, R W Bilous, A Gries, H Keen, J H Fuller, G Menzinger.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health; Hoechst Marion Roussel

Mesh：

Substances：

Year:  1997        PMID： 9250200     DOI： 10.1016/s0140-6736(97)26029-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.

Authors:  M Lièvre; J Ménard; E Bruckert; J Cogneau; F Delahaye; P Giral; E Leitersdorf; G Luc; L Masana; P Moulin; P Passa; D Pouchain; G Siest
Journal:  BMJ       Date:  2001-03-10

Review 2.  Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.

Authors:  A S Iltis
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

3.  Retinylamine Benefits Early Diabetic Retinopathy in Mice.

Authors:  Haitao Liu; Jie Tang; Yunpeng Du; Chieh Allen Lee; Marcin Golczak; Arivalagan Muthusamy; David A Antonetti; Alexander A Veenstra; Jaume Amengual; Johannes von Lintig; Krzysztof Palczewski; Timothy S Kern
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

4.  Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.

Authors:  Benjamin Carlisle; Jonathan Kimmelman; Tim Ramsay; Nathalie MacKinnon
Journal:  Clin Trials       Date:  2014-12-04       Impact factor: 2.486

5.  Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?

Authors:  Peter B Berger; Judson B Williams; Vic Hasselblad; Karen Chiswell; Karen S Pieper; Robert M Califf
Journal:  J Interv Cardiol       Date:  2013-02-05       Impact factor: 2.279

6.  Implications of product withdrawal on a post-approval pragmatic trial: The VOLUME study experience.

Authors:  Francesca M Kolitsopoulos; Nicolle M Gatto; Kevin Sweetland; Michael B Bracken; Neville Jackson
Journal:  Contemp Clin Trials Commun       Date:  2019-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.